Korea Q1 Roundup: Mixed Earnings, Gearing For Possible US Tariffs

World-First Approval For Novel Anthrax Vaccine

 
• By Jung Won Shin
  
first quarter results
SK Biopharm, Yuhan Benefited From Global Sales Of Flagship New Drugs (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from South Korea